Glucose monitoring is a key component of diabetes management, and may include glycated haemoglobin (HbA1c) monitoring, self-monitoring of blood...
Type 1 diabetes (T1D) is characterised by lifelong insulin deficiency and elevated blood glucose levels resulting from the loss of pancreatic beta...
This is the third article on research methods, following on from previous articles in the June and September editions of the ADE on levels of...
The prevalence of type 2 diabetes (T2D) continues to increase steadily as more people live longer. However, our ability to manage this condition in older...
An increasing number of people are using diabetes technologies as part of their diabetes management, including continuous glucose monitoring (CGM),...
Insulin pump therapy for Australians with type 1 diabetes (T1D) is funded either by self-purchase, private health insurance...